Bruker Announces René Lenggenhager as BioSpin Group President
13 October 2015 - 10:00PM
Business Wire
Bruker today announces the appointment of Dr. René Lenggenhager
as President of the Bruker BioSpin Group, effective November 1st,
2015. René has over 25 years of management experience in
international high-tech companies and in the scientific instruments
industry, where his responsibilities have included general
management with P&L responsibility for a global business,
marketing, R&D and global operations. René has extensive
experience with complex transformations, operational excellence,
lean manufacturing, marketing and value selling. Moreover, René has
a very successful track record in sustainable, profitable growth
with a focus on customers and innovation.
This Smart News Release features multimedia.
View the full release here:
http://www.businesswire.com/news/home/20151013005107/en/
René Lenggenhager, BioSpin, Mettler
Toledo, Bruker, analytical instruments, analytical solutions
(Photo: Business Wire).
Since 2004, Dr. Lenggenhager has served as General Manager for
Laboratory Weighing at METTLER TOLEDO (MTD). From 2000 until 2003,
he was the Head of R&D of Laboratory & Weighing
Technologies at MTD. Previously, he worked at the Siemens Building
Technologies SBT Cerberus Division, at Cerberus AG, at Landis &
Gyr AG and at Metrohm AG. René holds a Ph.D. in physics from the
Swiss Federal Institute of Technology (ETH), Zurich, a Bachelor of
Science in electronics from the University of Applied Sciences NTB,
Buchs, and an Executive MBA from University of St. Gallen, all in
Switzerland.
Frank Laukien, President and CEO of Bruker Corporation, said: “I
am very pleased to welcome René to Bruker. His success in our
industry, his broad technical background, and his passion for
innovation and customers are impressive. His outstanding track
record with operational excellence, profitable growth and margin
enhancement make René a compelling Group President to lead Bruker
BioSpin to the next level.”
Dr. René Lenggenhager commented: “Bruker has a strong reputation
for excellence in the customer community, with high-performance
instruments and high-value analytical solutions. Bruker BioSpin is
making progress with its transformation and recent new product
launches, and I am excited to join this creative team to drive
profitable growth and value for our customers and shareholders. I
am committed to business success and to providing the best
solutions to make our customers successful, and to develop new
applications that will improve the quality of human life.”
About Bruker Corporation (NASDAQ: BRKR)
For more than 50 years, Bruker has enabled scientists to make
breakthrough discoveries and develop new applications that improve
the quality of human life. Bruker’s high-performance scientific
research instruments and high-value analytical solutions enable
scientists to explore life and materials at molecular, cellular and
microscopic levels. In close cooperation with our customers, Bruker
is enabling innovation, productivity and customer success in life
science molecular research, in applied and pharma applications, in
microscopy, nano-analysis and industrial applications, as well as
in cell biology, preclinical imaging, clinical research,
microbiology and molecular diagnostics.
For more information, please visit: www.bruker.com
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151013005107/en/
Media Contact:Bruker CorporationDr. Thorsten Thiel, +49
(721) 5161 – 6500Director of Marketing
Communicationsthorsten.thiel@bruker.comorInvestor
Contact:Bruker CorporationJoshua Young, +1-978-667–9580, ext.
1479Vice President, Investor Relationsjoshua.young@bruker.com
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bruker (NASDAQ:BRKR)
Historical Stock Chart
From Jul 2023 to Jul 2024